Furthermore, a recent study suggested that miR-34a may be a promising target for the treatment of atherosclerosis as prevents cell growth and promotes apoptosis in atherosclerosis by regulating Bcl2, while deletion of miR-34a ameliorates atherosclerotic lesions in high-fat diet induced ApoE−/− mice (87). This evidence concerns the gene BCL2 and atherosclerosis.